In order to improve the life quality of cancer patients and to prolong their lives, IFuda Cancer Hospital dedicates to a new tumor therapy model which is called "3C+P" model. This model is combined with four therapy methods to provide patients systemic, comprehensive and personalized therapies, including cryosurgery ablation(CSA), microvascular interventional therapy(CMI), combined immunotherapy for cancer(CIC) and personalized cancer therapies.
Personalized cancer therapy, founded on the knowledge of cancer genome information and the mechanism of tumorigenesis, is a brand new model for cancer therapies. Nowadays, human being has entered an era of genome and researchers have different perspectives to contemplate the mechanism of tumorigenesis, cancer diagnosis and therapies. Up until now, we have known that each kind of tumor has its specific biological features and its heterogeneity features. Even suffered from the same kind of cancer, different patients would have different pathogenic factors, different mutational genes. Thus, personalized treatments for them are highly recommended. Personalized cancer therapies have now become an inevitable trend in the world of cancer treatments. According to each patient's gene information, doctors can give more accurate diagnosis and appropriate treatment recommendations.